Summary
16.95 -0.19(-1.13%)09/06/2024
Companhia de Saneamento Basico do Estado de Sao Paulo. (SBS)
Companhia de Saneamento Basico do Estado de Sao Paulo. (SBS)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.13 | 1.00 | 7.12 | 15.25 | 5.39 | 45.66 | 42.94 | 1,858.39 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 16.95 | |
| Open | 17.23 | |
| High | 17.28 | |
| Low | 16.89 | |
| Volume | 778,804 | |
| Change | -0.19 | |
| Change % | -1.13 | |
| Avg Volume (20 Days) | 1,084,360 | |
| Volume/Avg Volume (20 Days) Ratio | 0.72 | |
| 52 Week Range | 11.29 - 18.36 | |
| Price vs 52 Week High | -7.70% | |
| Price vs 52 Week Low | 50.11% | |
| Range | -1.64 | |
| Gap Up/Down | 0.07 | |
Fundamentals | ||
| Market Capitalization (Mln) | 11,585 | |
| EBIDTA | 9,338,986,496 | |
| PE Ratio | 14.9604 | |
| PEG Ratio | 2.5500 | |
| WallStreet Target Price | 18.51 | |
| Book Value | 44.9050 | |
| Earnings Per Share | 1.0100 | |
| EPS Estimate Current Quarter | 0.2400 | |
| EPS Estimate Next Quarter | 0.2900 | |
| EPS Estimate Current Year | 1.1800 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | 1.0100 | |
| Revenues | ||
| Profit Marging | 0.1362 | |
| Operating Marging (TTM) | 0.2502 | |
| Return on asset (TTM) | 0.0674 | |
| Return on equity (TTM) | 0.1225 | |
| Revenue TTM | 26,433,933,312 | |
| Revenue per share TTM | 38.6780 | |
| Quarterly Revenue Growth (YOY) | 0.1510 | |
| Quarterly Earnings Growth (YOY) | 0.1020 | |
| Gross Profit (TTM) | 7,704,817,000 | |
| Dividends | ||
| Dividend Share | 1.4400 | |
| Dividend Yield | 0.0186 | |
| Valuations | ||
| Trailing PE | 14.9604 | |
| Forward PE | 10.1523 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.8487 | |
| Revenue Enterprise Value | 0.5888 | |
| EBITDA Enterprise Value | 1.6760 | |
| Shares | ||
| Shares Outstanding | 683,510,016 | |
| Shares Float | 339,853,443 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.02 | |
| Insider (%) | 0.00 | |
| Institutions (%) | 11.19 | |
08/27 10:00 EST - accesswire.com
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that the country of Jordan's Industrial Property Protection Directorate has issued a new patent to Jaguar family company Napo Pharmaceuticals (Napo) for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very pleased that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that the country of Jordan's Industrial Property Protection Directorate has issued a new patent to Jaguar family company Napo Pharmaceuticals (Napo) for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very pleased that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
08/19 10:00 EST - accesswire.com
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Hong Kong's Intellectual Property Department has issued a new patent to Jaguar family company Napo Pharmaceuticals for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very happy that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Hong Kong's Intellectual Property Department has issued a new patent to Jaguar family company Napo Pharmaceuticals for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very happy that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
08/19 09:50 EST - zacks.com
Here's Why Momentum in Sabesp (SBS) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here's Why Momentum in Sabesp (SBS) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
06/13 11:20 EST - zacks.com
Here's Why Sabesp (SBS) is Poised for a Turnaround After Losing -11.66% in 4 Weeks
Sabesp (SBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why Sabesp (SBS) is Poised for a Turnaround After Losing -11.66% in 4 Weeks
Sabesp (SBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
06/12 12:40 EST - zacks.com
SBS or GWRS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks presents investors with the better value opportunity right now?
SBS or GWRS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks presents investors with the better value opportunity right now?
06/12 10:45 EST - zacks.com
Should Value Investors Buy Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
05/21 06:00 EST - businesswire.com
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of once-weekly subcutaneous apraglutide in adult patients with short bowel syndrome with intestinal failure (SBS-IF). These findings build on the positive topline data that Ironwood previously announced in February 202.
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of once-weekly subcutaneous apraglutide in adult patients with short bowel syndrome with intestinal failure (SBS-IF). These findings build on the positive topline data that Ironwood previously announced in February 202.
05/10 22:59 EST - seekingalpha.com
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2024 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q1 2024 Earnings Conference Call May 10, 2024 10:00 AM ET Company Participants Luiz Roberto Tiberio - IR Superintendent André Salcedo - CEO Catia Pereira - CFO and IR Officer Conference Call Participants Luiz Roberto Tiberio Hello. Good morning, everyone, and welcome to our earnings call for Q1 2024.
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2024 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q1 2024 Earnings Conference Call May 10, 2024 10:00 AM ET Company Participants Luiz Roberto Tiberio - IR Superintendent André Salcedo - CEO Catia Pereira - CFO and IR Officer Conference Call Participants Luiz Roberto Tiberio Hello. Good morning, everyone, and welcome to our earnings call for Q1 2024.
03/26 09:51 EST - zacks.com
What Makes Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) a Good Fit for 'Trend Investing'
If you are looking for stocks that are well positioned to maintain their recent uptrend, Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
What Makes Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) a Good Fit for 'Trend Investing'
If you are looking for stocks that are well positioned to maintain their recent uptrend, Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
03/22 15:36 EST - seekingalpha.com
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
03/08 12:41 EST - zacks.com
SBS vs. GWRS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks offers value investors a better bang for their buck right now?
SBS vs. GWRS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks offers value investors a better bang for their buck right now?
03/08 09:51 EST - zacks.com
Here's Why 'Trend' Investors Would Love Betting on Sabesp (SBS)
Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's Why 'Trend' Investors Would Love Betting on Sabesp (SBS)
Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
11/30 06:29 EST - seekingalpha.com
Sabesp: Privatization Just Around The Corner, Q3 Results Still Provide Room For Upside
Privatization of Brazilian water management company Sabesp is progressing, with a likely completion by the first half of 2024. The regulatory terms of the privatization will determine the company's long-term efficiency and potential for growth. The optimistic scenario envisions efficiency gains and a potential EV/RAB increase to 1.5x, suggesting a substantial upside.
Sabesp: Privatization Just Around The Corner, Q3 Results Still Provide Room For Upside
Privatization of Brazilian water management company Sabesp is progressing, with a likely completion by the first half of 2024. The regulatory terms of the privatization will determine the company's long-term efficiency and potential for growth. The optimistic scenario envisions efficiency gains and a potential EV/RAB increase to 1.5x, suggesting a substantial upside.
11/10 13:05 EST - seekingalpha.com
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2023 Earnings Conference Call November 10, 2023 9:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of IR Andre Salcedo - CEO Catia Pereira - CFO and IRO Conference Call Participants Luiz Roberto Tiberio Good morning, everyone. Welcome to the Earnings Conference Call for SABESP for the Third Quarter.
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2023 Earnings Conference Call November 10, 2023 9:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of IR Andre Salcedo - CEO Catia Pereira - CFO and IRO Conference Call Participants Luiz Roberto Tiberio Good morning, everyone. Welcome to the Earnings Conference Call for SABESP for the Third Quarter.
09/10 23:15 EST - seekingalpha.com
Sabesp: Privatization Gains Momentum, Stock Is A Buy (Rating Upgrade)
Sabesp's significant steps toward privatization, including the approval of privatization guidelines and a follow-on model, have boosted confidence in the company's prospects. In Q2, Sabesp reported robust financial results, with recurring EBITDA increasing significantly year-over-year. Sabesp's current valuation, with the potential for reduced cost of capital and improved long-term operating performance as a private sector company, suggests significant upside potential.
Sabesp: Privatization Gains Momentum, Stock Is A Buy (Rating Upgrade)
Sabesp's significant steps toward privatization, including the approval of privatization guidelines and a follow-on model, have boosted confidence in the company's prospects. In Q2, Sabesp reported robust financial results, with recurring EBITDA increasing significantly year-over-year. Sabesp's current valuation, with the potential for reduced cost of capital and improved long-term operating performance as a private sector company, suggests significant upside potential.
08/11 19:03 EST - seekingalpha.com
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q2 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q2 2023 Earnings Conference Call August 11, 2023 10:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of Investor Relations Andre Salcedo - Chief Executive Officer Catia Pereira - Chief Financial Officer and Investor Relations Officer Luiz Roberto Tiberio Good morning. Welcome to the SABESP Second Quarter Earnings Release Call.
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q2 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q2 2023 Earnings Conference Call August 11, 2023 10:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of Investor Relations Andre Salcedo - Chief Executive Officer Catia Pereira - Chief Financial Officer and Investor Relations Officer Luiz Roberto Tiberio Good morning. Welcome to the SABESP Second Quarter Earnings Release Call.
07/06 04:54 EST - seekingalpha.com
Sabesp Stock: Evaluating Privatization's Impact, Neutral Stance
The potential privatization of the Brazilian water and waste management company, Sabesp, has impacted its shares, presenting an opportunity to enhance the company's efficiency. Sabesp's recent earnings results were satisfactory, showcasing a 17% year-over-year increase in net operating revenues despite recent volatility and a drop in net income, albeit with minor setbacks. While the company currently trades at an undervalued price, I adopt a cautious approach due to the risks associated with the changes of "Basic Sanitation Legal Framework" in Brazil.
Sabesp Stock: Evaluating Privatization's Impact, Neutral Stance
The potential privatization of the Brazilian water and waste management company, Sabesp, has impacted its shares, presenting an opportunity to enhance the company's efficiency. Sabesp's recent earnings results were satisfactory, showcasing a 17% year-over-year increase in net operating revenues despite recent volatility and a drop in net income, albeit with minor setbacks. While the company currently trades at an undervalued price, I adopt a cautious approach due to the risks associated with the changes of "Basic Sanitation Legal Framework" in Brazil.
03/16 10:25 EST - headlinesoftoday.com
Survey & Ballot Systems Launches Text Message Invites for Increased Voter Engagement
SBS launches verified text message invites to help member organizations increase voter participation within director elections, bylaw votes, mergers and contract ratification votes. EDEN PRAIRIE, Minn., March 16, 2023 /PRNewswire-PRWeb/ — Survey & Ballot Systems (SBS), a leading provider of online voting and governance software solutions, is excited to announce the launch of its newest […]...
Survey & Ballot Systems Launches Text Message Invites for Increased Voter Engagement
SBS launches verified text message invites to help member organizations increase voter participation within director elections, bylaw votes, mergers and contract ratification votes. EDEN PRAIRIE, Minn., March 16, 2023 /PRNewswire-PRWeb/ — Survey & Ballot Systems (SBS), a leading provider of online voting and governance software solutions, is excited to announce the launch of its newest […]...
11/17 14:00 EST - seekingalpha.com
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2022 - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP. (NYSE:SBS ) Q3 2022 Earnings Conference Call November 17, 2022 9:00 AM ET Company Participants Luiz Tiberio - Resource Funding and IRO Officer Benedito Braga - Chief Executive Officer of SABESP Osvaldo Garcia - Chief Financial Officer and Investor Relations Officer Marcelo Miyagui - Superintendent for Accounting Conference Call Participants Carolina Carneiro - Credit Suisse Henrique Peretti - JPMorgan Operator Good morning, everyone.
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2022 - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP. (NYSE:SBS ) Q3 2022 Earnings Conference Call November 17, 2022 9:00 AM ET Company Participants Luiz Tiberio - Resource Funding and IRO Officer Benedito Braga - Chief Executive Officer of SABESP Osvaldo Garcia - Chief Financial Officer and Investor Relations Officer Marcelo Miyagui - Superintendent for Accounting Conference Call Participants Carolina Carneiro - Credit Suisse Henrique Peretti - JPMorgan Operator Good morning, everyone.
10/03 14:43 EST - investorplace.com
Brazil Election Sends EWZ, SBS, VALE, PBR Stocks Soaring Today
Today's broad-based rally has provided a key lift for many top stocks in investors' portfolios. That said, among the biggest gainers today is an intriguing group of stocks.
Brazil Election Sends EWZ, SBS, VALE, PBR Stocks Soaring Today
Today's broad-based rally has provided a key lift for many top stocks in investors' portfolios. That said, among the biggest gainers today is an intriguing group of stocks.